The association of the PTPN22 620W polymorphism with Behcet's disease

被引:37
作者
Baranathan, Vijay
Stanford, Miles R.
Vaughan, Robert W.
Kondeatis, Elli
Graham, Elizabeth
Fortune, Farida
Madanat, Wafa
Kanawati, Charlie
Ghabra, Marwen
Murray, Philip I.
Wallace, Graham R. [1 ]
机构
[1] Univ Birmingham, Acad Unit Ophthalmol, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England
[2] Univ London, Dept Oral Med, Queen Mary, London WC1E 7HU, England
[3] Jordan Hosp, Amman, Jordan
[4] St John Eye Hosp, Jerusalem, Israel
[5] Univ Hosp, Damascus, Syria
[6] Guys Hosp, Sch Med, Dept Ophthalmol, London, England
[7] Guys Hosp, Clin Transplantat Lab, London, England
[8] St Thomas Hosp, Clin Transplantat Lab, London, England
关键词
D O I
10.1136/ard.2007.073866
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: A single nucleotide polymorphism ( SNP) of the gene encoding protein tyrosine phosphatase type 22 ( PTPN22 620W) has recently been described as a strong common genetic risk factor for human autoimmune disease. We have analysed the association of PTPN22 620W in patients with Behc, et's disease ( BD). Methods: Genomic DNA was obtained from 270 patients with BD from the UK and the Middle East. Normal controls ( n = 203) were collected from the same populations. Patients with idiopathic retinal vasculitis from the UK ( n = 136) were used as disease controls. PTPN22 620W was detected by SSP PCR analysis and agarose gel electrophoresis. Results: The results showed an inverse correlation between the presence of PTPN22 620W and Behc, et's disease in either patient group tested. There was a greatly reduced prevalence in Middle Eastern compared to UK patients and controls. Finally, there was no association with either UK patients with retinal vasculitis compared with UK controls. Conclusions: The presence of PTPN22 620W was inversely associated with BD and the distribution of the SNP in the Middle East supports previous findings in the global prevalence.
引用
收藏
页码:1531 / 1533
页数:3
相关论文
共 15 条
[1]  
BONFIOLI AA, 2004, SEMIN OPHTHALMOL, V20, P199
[2]   A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes [J].
Bottini, N ;
Musumeci, L ;
Alonso, A ;
Rahmouni, S ;
Nika, K ;
Rostamkhani, M ;
MacMurray, J ;
Meloni, GF ;
Lucarelli, P ;
Pellecchia, M ;
Eisenbarth, GS ;
Comings, D ;
Mustelin, T .
NATURE GENETICS, 2004, 36 (04) :337-338
[3]   Role of PTPN22 in type 1 diabetes and other autoimmune diseases [J].
Bottini, Nunzio ;
Vang, Torkel ;
Cucca, Francesco ;
Mustelin, Tomas .
SEMINARS IN IMMUNOLOGY, 2006, 18 (04) :207-213
[4]   PTPN22 and invasive bacterial disease [J].
Chapman, SJ ;
Khor, CC ;
O Vannberg, F ;
Maskell, NA ;
Davies, CW ;
Hedley, EL ;
Segal, S ;
Moore, CE ;
Knox, K ;
Day, NP ;
Gillespie, SH ;
Crook, DW ;
Davies, RJ ;
Hill, AV .
NATURE GENETICS, 2006, 38 (05) :499-500
[5]  
CHEN Y, 2005, BR J OPHTHALMOL, V89, P1013
[6]   Genetic influence of PTPN22 R620W polymorphism in tuberculosis [J].
Gomez, Luis M. ;
Anaya, Juan-Manuel ;
Martin, Javier .
HUMAN IMMUNOLOGY, 2005, 66 (12) :1242-1247
[7]   PTPN22: Setting thresholds for autoimmunity [J].
Gregersen, Peter K. ;
Lee, Hye-Soon ;
Batliwalla, Franak ;
Begovich, Ann B. .
SEMINARS IN IMMUNOLOGY, 2006, 18 (04) :214-223
[8]  
Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894
[9]   Systematic search for single nucleotide polymorphisms in a lymphoid tyrosine phosphatase gene (PTPN22):: Association between a promoter polymorphism and type I diabetes in Asian populations [J].
Kawasaki, E ;
Awata, T ;
Ikegami, H ;
Kobayashi, T ;
Maruyama, T ;
Nakanishi, K ;
Shimada, A ;
Uga, M ;
Kurihara, S ;
Kawabata, Y ;
Tanaka, S ;
Kanazawa, Y ;
Lee, I ;
Eguchi, K .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2006, 140A (06) :586-593
[10]   Role of HLA-B51 and HLA-B52 in susceptibility to pulmonary tuberculosis [J].
Lakshmi, V. Vijaya ;
Rakh, Shilpa S. ;
Radha, B. Anu ;
Priya, V. Hari Sai ;
Pantula, Vinod ;
Jasti, Susmita ;
Latha, G. Suman ;
Murthy, K. J. R. .
INFECTION GENETICS AND EVOLUTION, 2006, 6 (06) :436-439